...
TOIMICRO

The Oncology Institute, Inc.

HealthcareMedical - Care Facilities
$2.89
$0.00(-3.02%)
52W$0.60
$4.88
FinancialsValuationvs FMS
Updated Mar 3, 12:00 AM
RSI55
RS Rating26/99
Beta1.56
Volatility103%
F-Score3/9
Mkt Cap$219M
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

The Oncology Institute, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 26), showing significant lag compared to the market leaders. Earnings growth of 22% provides fundamental context to the price action. Investors should exercise caution due to high volatility (103% annualized), which requires wider risk management.

Relative Strength
26
out of 99
Lagging
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
1.56
vs S&P 500
HIGH BETA
52W Position
53%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$3.18
50 SMA > 100 SMA$3.46
100 SMA > 150 SMA$3.50
150 SMA > 200 SMA$3.33

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$2.64+9.62%ABOVE
50 SMA$3.18-9.03%BELOW
100 SMA$3.46-16.58%BELOW
150 SMA$3.50-17.41%BELOW
200 SMA$3.33-13.32%BELOW

Price Performance

1D-3.0%
1W+13.3%
1M-3.7%
3M-8.0%
6M-17.0%
YTD-21.3%
1Y+239.2%
3Y+27.0%
52-Week Trading Range53% from low
$2.89
52W Low$0.60
52W High$4.88

Technical Indicators

RSI (14)NEUTRAL
55.5
305070
VCP ScoreCOOL
5/10
Base depth: 74.9%

Risk Profile

Beta
1.56
52W Vol
103%
ATR
$0.20
Max DD (1Y)
-50%

Volume Analysis

Today
2
50D Avg
1.55M
Vol Ratio
0.00x
Liquidity
ILLIQUID

Earnings Momentum

Q4'24+33%
$-0.14
Q1'25+5%
$-0.21
Q2'25+12%
$-0.15
Q3'25+22%
$-0.14
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:—
5 Years:+20.41%
3 Years:+24.68%
TTM:+21.67%

Compounded Profit Growth

10 Years:—
5 Years:—
3 Years:—
TTM:+17.95%

Stock Price CAGR

10 Years:-11.40%
5 Years:-23.32%
3 Years:+27.03%
1 Year:+239.16%

Return on Equity

10Y Avg:-62.0%
5Y Avg:-72.5%
3Y Avg:-101.8%
Last Year:-213.4%

Key Metrics

Market Cap$219M
Gross Margin13.7%
Net Margin-16.4%
Piotroski F-Score3/9

More TOI Analysis

Full Financial AnalysisDCF & Intrinsic ValueTotal Return Calculator

Compare With

TOI vs FMSFMSDVACCM

Data Dictionary

RS Rating (Relative Strength)

Measures 12-month price performance vs all stocks. Rating of 26 meansTOI outperformed 26% of all stocks. Scores >80 indicate market leaders.

Beta

Measures volatility vs S&P 500. Beta of 1.56 means 56% more volatile than market.

Piotroski F-Score

9-point financial strength score based on profitability, leverage, and efficiency. Score of 3/9. Scores 7-9 = strong, 4-6 average, 0-3 = weak.

VCP (Volatility Contraction Pattern)

Measures base formation quality. Higher scores indicate tighter consolidation near pivot points. Score of 5/10 with COOL status.

Frequently Asked Questions

Is TOI in an uptrend right now?

TOI has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is TOI overbought or oversold?

TOI's RSI (14) is 55. The stock is in neutral territory, neither overbought nor oversold.

Is TOI outperforming the market?

TOI has a Relative Strength (RS) Rating of 26 out of 99. TOI is currently lagging the broader market.

Where is TOI in its 52-week range?

TOI is trading at $2.89, which is 59% of its 52-week high ($4.88) and 53% above its 52-week low ($0.60).

How volatile is TOI?

TOI has a Beta of 1.56 and 52-week volatility of 103%. It's more volatile than the S&P 500 - expect bigger swings.